Real-world evaluation of pembrolizumab monotherapy for PD-L1 positive (TPS > 50%) metastatic NSCLC in France

Affiliation auteurs!!!! Error affiliation !!!!
TitreReal-world evaluation of pembrolizumab monotherapy for PD-L1 positive (TPS > 50%) metastatic NSCLC in France
Type de publicationJournal Article
Year of Publication2021
AuteursPerol M., Filleron T., Quantin X., Chouaid C., C. Valette A, Lena H., Kaderbhai C., Fabre C., Santorelli M., Bensimon L., Burke T., Couch D., Nguyen E., Courtinard C., Grp ESMELung Canc
JournalJOURNAL OF THORACIC ONCOLOGY
Volume16
PaginationS757-S758
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN1556-0864